Wall Street Analysts Believe Theravance Bio (TBPH) Could Rally 42.15%: Here's is How to Trade

Shares of Theravance Biopharma (TBPH) have gained 1.7% over the past four weeks to close the last trading session at $18.79, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $26.71 indicates a potential upside of 42.2%.The average comprises seven short-term price targets ranging from a low of $13.00 to a high of $42.00, with a standard deviation of $11.1. While the lowest estimat ...